Archangels leads on £12.4m of investment in Scottish innovators in H1 2021

Dylan MacdonaldArchangels

Investment includes record-breaking contribution from Archangels’ syndicate members The Edinburgh-based business investment group, Archangels, has led investment of £12.4m in innovative Scottish tech and life sciences companies in the first half of 2021 (H1 2020: £9.5m) Archangels’ H1 2021 deals data, released today (14th July 2021), reveals that Archangels itself invested £7.3m during the first six months of 2021, with co-investment …

Mike Rutterford wins Lifetime Achievement Award at UKBAA Angel Investment Awards

Dylan MacdonaldArchangels

Mike Rutterford has won the Lifetime Achievement Award at the UKBAA Angel Investment Awards. Mike is a serial entrepreneur with a 40-year career as a business angel and in property investment. Educated in Edinburgh, in his 20s he launched Stuart Wyse Ogilivie and over a ten-year period developed the estate agency into the biggest in Scotland – subsequently selling to …

Investment to respond to growth in demand for integrated services at UK drug delivery company BDD

Dylan MacdonaldArchangels

Backing to fund the further expansion of formulation and manufacturing capabilities underpinned by strategic senior appointments Innovative Scottish-based drug delivery company, Bio-Images Drug Delivery Limited (BDD), has positioned itself for rapid growth with a further round of investment in its GMP* manufacturing capabilities alongside strategic recruitment to the senior leadership team and the Board of Directors. The £1.2m investment, has …

Dr Miroslav Ravic CEO MGB Biopharma

MGB Biopharma announces successful outcome from phase II clinical study on MGB-BP-3 for the treatment of Clostridium difficile infection

Dylan Macdonaldblog

MGB Biopharma, the Glasgow-based biopharmaceutical company developing a novel class of anti-infectives, today announces the successful conclusion of its Phase II clinical study into MGB-BP-3, for the treatment of Clostridium difficile Infection (CDI). The study confirms that the drug has the potential to become the new gold standard, first-line treatment for CDI. CDI is a serious and often life-threatening infection of the large intestine …

Archangels leads further investment in home-grown Scottish innovators

Dylan Macdonaldblog

Archangels, the Edinburgh-based business angel investment syndicate – believed to be the oldest in the world – has led investment of £6.2 million in Scottish early stage companies in the first quarter of 2020. Four tech and life sciences businesses – Blackford Analysis; Fios Genomics; Optoscribe; and Speech Graphics – were the recipients of the additional investment. £2.6 million came …

Oproscribe - Waferscale fabrication of fanout

Scottish-based Optoscribe announces investment round from Archangels, Maven and Par Equity

Dylan Macdonaldblog

Optoscribe Ltd, a world-leading supplier of 3D glass-based integrated photonics components, today announced that the company has closed its latest investment round. This funding round, which was led by Scottish business angel investment syndicate, Archangels, with participation from Maven Capital Partners, Par Equity and Scottish Investment Bank, will facilitate the continued expansion of the business and enable extended commercial engagement. …

Calcivis CEO Adam Christie

Edinburgh-based CALCIVIS receives Approvable Letter from FDA

Dylan Macdonaldblog

Edinburgh, March 5th 2020 – CALCIVIS, a medical devices company focused on modernising the management of tooth decay and enabling preventive dentistry, announces receipt of an Approvable Letter for the Premarket Approval (PMA) of its CALCIVIS® Imaging System from the US Food and Drug Administration (FDA). CALCIVIS intends to introduce this novel product in the US in 2021 with the …